Amy L Shaver

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 7

Top Topics

Prostate Cancer

Physical Activity

Top Venues

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Amy L Shaver, Nikita Nikita, Swapnil Sharma, Daniel S Lefler, Atrayee Basu-Mallick, Jennifer M Johnson, Meghan L Butryn, Grace Lu-Yao
Understanding the role of sex on outcomes for the cancer patient undergoing treatment with immune checkpoint inhibitors: a scoping review protocol. BMJ open 12 (7) (2022)
Yash B Shah, Amy L Shaver, William Kevin Kelly, Grace Lu-Yao
A scoping review protocol to elucidate outcomes following abiraterone versus enzalutamide for prostate cancer. PloS one 17 (8) (2022)
Yash B Shah, Amy L Shaver, Jacob Beiriger, Sagar Mehta, Nikita Nikita, William Kevin Kelly, Stephen J Freedland, Grace L Lu-Yao
Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review. Cancers 14 (15) (2022)
Amy L Shaver, Swapnil Sharma, Nikita Nikita, Daniel S Lefler, Atrayee Basu-Mallick, Jennifer M Johnson, Meghan Butryn, Grace L Lu-Yao
The Effects of Physical Activity on Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors: A Scoping Review. Cancers 13 (24) (2021)
Amy L Shaver, Collin M Clark, Mary Hejna, Steven Feuerstein, Robert G Wahler, David M Jacobs
Trends in fall-related mortality and fall risk increasing drugs among older individuals in the United States,1999-2017. Pharmacoepidemiology and drug safety 30 (8) (2021)
Amy L Shaver, Theresa A Tufuor, Jing Nie, Shauna Ekimura, Keri Marshall, Susan Hazels Mitmesser, Katia Noyes
Cost-Effectiveness of Nutrient Supplementation in Cancer Survivors. Cancers 13 (24) (2021)
Amy L Shaver, David M Jacobs, Michael J LaMonte, Katia Noyes
Antibiotic prescribing for acute respiratory tract infections in the United States outpatient setting. BMC family practice 20 (1) (2019)